A Blood Test For Irritable Bowel Syndrome Can Help Build A Better Diet

Updated Feb 28, 2025 | 02:00 AM IST

SummaryAllergies, food intolerances and many other conditions often restrict people to a certain diet. Often people try some foods to realize whether they can eat it or not and that can cause harm or discomfort to them even if it isn’t long term. But a new test may resolve the trial and removal method all together!
(Credit-Canva)

Diet plays a very important role when it comes to your health. There are many people who have to adhere to strict diets because of certain conditions they have. While the basic understanding that we need all kinds of foods to fulfill our body’s needs, sometimes these foods can also cause harm to your body. For example, lactose intolerant people cannot eat or consume any kind of dairy product as their bodies do not have the necessary compounds, known as lactose, to break down dairy foods. Similarly, there are many foods that may be ok for others to consume, but not for people who have digestive issues like IBS. But this new clinical trial may be able to help us know what food we can eat based on our blood test! The blood test, called inFoods IBS, looks for a special type of antibody in the blood. Antibodies are like tiny soldiers that our bodies make to fight off things that could make us sick.

IBS is a very common problem, affecting a large number of people. Many people know that what they eat can make their IBS symptoms worse, but it's often hard to figure out exactly which foods are the culprits. This is because everyone is different, and what triggers one person might not trigger another. Doctors hear from patients all the time, asking for help in determining which foods are causing their problems. So, finding a reliable way to pinpoint those foods is important. This test is attempting to provide that reliability.

How Does This Blood Test Work?

Basically, the test is looking for an antibody called IgG. When the gut reacts badly to a food, it makes more of this IgG antibody. The test checks for reactions to 18 common foods, like wheat, milk, and certain fruits. If the test finds high levels of the IgG antibody for a certain food, it means that food is likely causing problems. Therefore, the patient should try to remove that food from their diet.

Many people with IBS struggle to find relief from their stomach pain and discomfort. This new study looked at whether a special blood test could help. The idea was to see if the test could tell people which foods were making their IBS worse. The results were encouraging. When people changed their diets based on what the blood test showed, about 60% of them felt less stomach pain. This is better than the 42% who felt better when they just tried a general diet change. This shows that the blood test might be a useful tool for people with IBS to get real relief.

How Does This Personalized Nutrition Approach Work?

Many doctors suggest that people with IBS try elimination diets, where they cut out certain foods to see if their symptoms improve. However, these diets can be very hard to follow, because they often require people to cut out a lot of different foods. Doctors are always looking for ways to give patients care that's tailored to their specific needs. In the case of IBS, that means figuring out exactly which foods each person should avoid.

This blood test is a step in that direction. Experts are calling it a move towards "precision nutrition." This means that instead of giving everyone the same diet advice, doctors could use the blood test to create a personalized plan for each patient. While more research is needed, this test brings hope that doctors will soon be able to give much more precise dietary recommendations to those people that suffer from IBS. While this test is yet to be approved by FDA, it could be a world of comfort and ease for people who suffer with IBS.

End of Article

Red VS White Patches In The Mouth: Which One Is A Sign Of Mouth Cancer?

Updated Jun 1, 2026 | 05:00 PM IST

SummaryMouth cancer incidence is on the rise in India. Smoking, alcohol intake, and chewing tobacco are some of the key causes.
oral cancer

If detected early, oral cancer can be treated. (Photo credit: AI generated)

Oral cancer cases are on the rise because of tobacco chewing, smoking, alcohol consumption, poor oral hygiene, and delayed medical attention. Many people ignore small red or white patches, which are early warning signs of cancer and should never be overlooked. There is an average delay of six months in cancer diagnosis, which is the reason patients are diagnosed with stage 3 and 4 cancers.

Dr Prathamesh Pai, Senior Consultant Head and Neck Surgical Oncologist, Gleneagles Hospital, Parel, Mumbai, explained the difference between red and white patches in the mouth and what they may indicate about your health.

Red vs White Patches in the Mouth

White patches inside the mouth are called leukoplakia, while red patches are known as erythroplakia. Both can occur on the tongue, gums, inner cheeks, or floor of the mouth. Though both need equal attention, red patches are more dangerous, with a higher risk of being cancerous in comparison to white patches. Red patches in the mouth indicate severe abnormal cellular changes, which can develop into precancerous conditions or cancer. Around 60% to 80% of erythroplakias are diagnosed as early-stage cancer on biopsy.

What is erythroplakia?

Erythroplakia is a fiery red, well-defined patch in the mouth. These lesions are velvety in appearance. They often appear on the floor of the mouth or the retromolar trigone (the area behind the wisdom teeth). Red patches often go unreported, as they are mistaken for traumatic mouth ulcers caused by hard foods or dental irritation.

If a red patch does not heal within two to three weeks, it should raise concerns about cancer. Besides the duration, patches that bleed on touch, are painful while eating, are associated with a burning sensation, difficulty swallowing, loosening of teeth, or voice changes should be investigated. Tobacco users should be even more mindful. Ignoring persistent red or white patches can allow the disease to progress silently.

So, make sure to seek immediate help and consult a doctor. For anyone presenting with red or white patches, the doctor will carry out a physical oral examination and a biopsy, in which a small tissue sample is taken from the patch for evaluation. A CT scan and MRI may also be advised, depending on the location of the patch and other clinical features.

Why early detection of cancer matters

Remember, early detection of cancer is curable. Treatment is also less extensive, often involving minor intraoral surgery and preservation of speech and swallowing functions. As the cancer stage advances, surgery may require the removal of parts of the cheek, jaw, or tongue, as well as postoperative radiotherapy. This affects the face and neck and hampers important functions such as eating, speaking, and swallowing. This has major implications for quality of life. Treatment can also be a financial burden, especially for younger patients.

Take charge of your life. Lead a happy, healthy life. Avoid tobacco, alcohol, and other addictions. Visit your dentist regularly and maintain good oral hygiene. Prevention is better than cure. In the case of any non-healing ulcers in the mouth, swelling in the neck, altered speech or swallowing, or altered bowel habits for more than two weeks despite treatment, do visit a doctor. Remember, early detection of cancer is curable.

End of Article

How Weather Changes Trigger Migraines, Neurologist Explains

Updated Jun 1, 2026 | 02:56 PM IST

SummaryWeather changes can affect brain chemistry by influencing serotonin levels, a neurotransmitter involved in migraine development.
How Weather Changes Trigger Migraines, Neurologist Explains

Credit: AI created image

New Delhi's weather is fluctuating sharply, with Western Disturbances driving bouts of intense heat and sudden pre-monsoon showers. The city is currently hovering in the mid-30s°C but is also bracing for a return to scorching heat, with maximum temperatures forecast to climb into the low to mid-40s°C this week.

Such weather fluctuations can play a significant role in triggering migraine attacks, said Dr. Vivek Kumar, Principal Director - Neurology, Max Super Speciality Hospital, Patparganj.

Weather Factors That Can Trigger Migraines

Speaking to HealthandMe, Dr. Vivek noted that many components of weather are reported to affect migraine. These include:

  • Barometric pressure
  • Humidity
  • Temperature
  • Seasons

Dr. Kumar explained that a drop in atmospheric pressure, often seen before storms, can create a pressure imbalance between the environment and the sinuses or inner ear, stimulating nerves and leading to headaches.

"Rapid temperature changes, as well as exposure to extreme heat or cold, can also trigger migraine episodes," he said.

Similarly, both high humidity and very dry air have been associated with the onset of migraine symptoms. Bright sunlight and intense sun exposure, particularly when reflected off surfaces such as snow or water, are also recognized migraine triggers.

Also read: Global Temperatures Likely To Stay Near Record Levels For Next Five Years: WMO

How Does The Weather Trigger Migraines?

According to Dr. Kumar, weather changes can affect brain chemistry by influencing serotonin levels, a neurotransmitter involved in migraine development. They may also contribute to inflammation or pressure differences within the sinuses.

Further, the expert noted that seasonal transitions can be particularly challenging.

"Spring and summer may trigger migraines because of heat and allergens, while winter's cold and dry air can also contribute to headaches and sinus discomfort," he said.

Notably, weather is often only one factor among several. Allergies during spring or viral illnesses during autumn may also combine with environmental changes to trigger headaches, Dr. Kumar stressed.

Migraine Vs Sinus Headache

Read More: What Can You Learn About Your Health From Ice Cream Headaches?

Migraine is also frequently mistaken for a sinus headache because the symptoms often overlap.

Dr. Kumar noted that migraine attacks can cause forehead and facial pressure, as well as nasal congestion or a runny nose. Unlike migraine, however, sinus infections may be accompanied by fever.

He explained that migraine can activate nerves in the face, a phenomenon known as cranial autonomic activation, which can create sensations of nasal blockage and congestion.

While weather changes are difficult to avoid, monitoring weather forecasts may help people prepare for potential triggers. Preventive treatment may also reduce sensitivity to environmental changes and allow greater freedom in daily activities.

Tips To Prevent Migraine

Dr. Kumar advised:

  • Keeping a migraine diary for at least 90 days to help identify specific weather-related patterns associated with attacks.
  • Treating migraine attacks early when weather-related triggers are suspected. Early treatment can shorten the duration of an attack and prevent symptoms from becoming severe.
  • Maintaining adequate hydration, particularly during hot weather or physical activity. Carrying water when outdoors can help compensate for fluid loss through sweating.
  • For those sensitive to bright sunlight, staying indoors during peak daylight hours may be beneficial. When outdoor exposure is unavoidable, protective sunglasses or hats can help reduce glare and light sensitivity.

End of Article

Pancreatic Cancer: What Is The Role Of Keratin 17 In Driving The Feared Disease?

Updated Jun 1, 2026 | 04:00 PM IST

SummaryA recent study by the researchers from Yale School of Medicine, led by Kenneth Shroyer and Natalia Marchenko, sheds light on the role of Keratin 17 in driving pancreatic cancer.
Pancreatic Cancer: What Is The Role Of Keratin 17 In Driving The Feared Disease?

Credit: Canva

Pancreatic cancer is one of the most feared diseases, and it causes thousands of lives to be wasted away due to this fatal disease. According to the Population-Based Cancer Registries (PBCRs) managed by the Indian Council of Medical Research (ICMR) and the IARC Global Cancer Observatory (GLOBOCAN), about 22,982 Indians have pancreatic cancer every year.

On the other hand, the American Cancer Society's US SEER Pancreatic Cancer Stat Facts shows the annual number of cases is 67,530. Thus, any lead to resisting cancer is good news for the world. Recently, a research team from Stony Brook Medicine and Luisa Escobar-Hoyos of Yale School of Medicine, led by Kenneth Shroyer and Natalia Marchenko, found an important fact to fight the fatal disease.

The study investigated the role of Keratin 17 (K17) and found that the protein can be a driver of chemoresistance to gemcitabine. It is often used to treat various types of cancer. The study shows that the K17 can act as a target for the development of novel treatments.

They discovered that the protein is a key driver of chemoresistance to gemcitabine, an agent used to treat a wide range of cancers, including advanced tumors of the pancreas, lungs, and breast.

How New Pancreatic Cancer Drug Daxorrasib Can Help You?

Daxaronrasib is a daily oral pill that has demonstrated statistically significant and clinically meaningful improvements in progression-free survival (PFS) and overall survival (OS) compared with standard intravenous chemotherapy.

Described as a multi-selective inhibitor of RAS(ON) proteins, it is the first investigational drug in a new class of RAS inhibitors designed to target a broad spectrum of cancer-causing RAS mutations.

The drug works by blocking KRAS signalling proteins that drive tumor growth.

Read More: New Pancreatic Cancer Drug Daxaronrasib May Benefit Patients With Lung And Ovarian Tumors Too

Daraxonrasib is the first drug. It works by pairing up with a protein called cyclophilin A inside cells, acting like a molecular glue, glomming onto the mutated protein.

Pancreatic cancer is considered one of the most RAS-dependent cancers, with more than 90 per cent of patients carrying tumours driven by RAS protein mutations. Similar RAS-targeting drugs are also being developed for pancreatic, lung, and colon cancers.

The findings were presented at a plenary session of the American Society of Clinical Oncology’s meeting in Chicago on May 31 and simultaneously published in the New England Journal of Medicine.

End of Article